|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
70,540,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,776,453 |
Avg
Vol: |
2,215,743 |
52
Week Range: |
$49.96 - $49.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Claypool William D Md |
Director |
|
2011-03-03 |
4 |
OE |
$2.94 |
$115,105 |
D/D |
38,641 |
85,000 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-12-31 |
4 |
OE |
$1.84 |
$4,600 |
D/D |
2,500 |
17,440 |
|
- |
|
Glaser Robert |
Director |
|
2010-12-14 |
4 |
S |
$16.75 |
$83,750 |
D/D |
(5,000) |
36,860 |
|
- |
|
Doyle Thomas F |
VP Strategic Initiatives |
|
2010-12-13 |
4 |
D |
$16.89 |
$141,251 |
D/D |
(8,363) |
52,444 |
|
- |
|
Doyle Thomas F |
VP Strategic Initiatives |
|
2010-12-13 |
4 |
OE |
$14.13 |
$141,250 |
D/D |
10,000 |
60,807 |
|
- |
|
Milano Vincent |
President and CEO |
|
2010-12-13 |
4 |
OE |
$14.13 |
$141,250 |
D/D |
10,000 |
74,390 |
|
- |
|
Milano Vincent |
President and CEO |
|
2010-12-13 |
4 |
D |
$16.89 |
$105,934 |
D/D |
(6,272) |
64,390 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2010-12-09 |
4 |
S |
$16.56 |
$220,248 |
D/D |
(13,300) |
569 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2010-12-09 |
4 |
OE |
$3.14 |
$43,115 |
D/D |
13,300 |
13,869 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2010-12-08 |
4 |
S |
$16.55 |
$19,860 |
D/D |
(1,200) |
569 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2010-12-08 |
4 |
OE |
$3.55 |
$4,260 |
D/D |
1,200 |
1,769 |
|
- |
|
Claypool William D Md |
Director |
|
2010-11-09 |
4 |
S |
$17.00 |
$108,290 |
D/D |
(6,359) |
60,000 |
|
- |
|
Claypool William D Md |
Director |
|
2010-11-09 |
4 |
OE |
$2.94 |
$18,695 |
D/D |
6,359 |
66,359 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-13 |
4 |
S |
$13.25 |
$67,207 |
D/D |
(5,060) |
15,113 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-13 |
4 |
OE |
$1.84 |
$9,310 |
D/D |
5,060 |
20,173 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-10 |
4 |
S |
$13.25 |
$104,692 |
D/D |
(7,900) |
15,113 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-10 |
4 |
OE |
$1.84 |
$14,536 |
D/D |
7,900 |
23,013 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-09 |
4 |
S |
$13.25 |
$225,867 |
D/D |
(17,040) |
15,113 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2010-09-09 |
4 |
OE |
$1.84 |
$31,354 |
D/D |
17,040 |
32,153 |
|
- |
|
Glaser Robert |
Director |
|
2010-05-27 |
4 |
S |
$12.50 |
$62,500 |
D/D |
(5,000) |
41,860 |
|
- |
|
Glaser Robert |
Director |
|
2010-05-27 |
4 |
OE |
$12.00 |
$60,000 |
D/D |
5,000 |
46,860 |
|
- |
|
Baker Felix |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$666,930 |
I/I |
(52,508) |
248,829 |
|
- |
|
Baker Felix |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$5,881,836 |
I/I |
(463,082) |
2,288,013 |
|
- |
|
Baker Felix |
10% Owner |
|
2010-05-07 |
4 |
S |
$12.46 |
$138,338 |
I/I |
(11,104) |
301,337 |
|
- |
|
Baker Felix |
10% Owner |
|
2010-05-07 |
4 |
S |
$12.46 |
$1,220,176 |
I/I |
(97,940) |
2,751,095 |
|
- |
|
412 Records found
|
|
Page 8 of 17 |
|
|